{
  "id": 1918,
  "text": "1620</td><td>2016</td><td>12</td><td> NAB-paclitaxel</td><td>nr</td><td>8.9</td></tr><tr><td>Garcia et al.1569</td><td>2007</td><td>27</td><td>Docetaxel</td><td>8.7</td><td>7</td></tr><tr><td>Angiogenesis inhibitors</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Monk et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1620</td><td>2016</td><td>12</td><td> NAB-paclitaxel</td><td>nr</td><td>8.9</td></tr><tr><td>Garcia et al.1569</td><td>2007</td><td>27</td><td>Docetaxel</td><td>8.7</td><td>7</td></tr><tr><td>Angiogenesis inhibitors</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Monk et al.\n\n<question>: ",
  "ChatGPT_response_0": "是的，有研究对抗血管生成药物进行了比较研究。其中一些药物如NAB-紫杉醇和多西紫杉醇等已经被研究比较其效果和副作用。这些抗血管生成药物被广泛用于癌症治疗中，研究比较它们的用途和效果对于指导临床实践具有重要意义。通过对不同抗血管生成药物进行比较研究，可以更好地了解它们在治疗中的表现和适用范围。",
  "query": "这些研究中是否有针对抗血管生成药物的比较研究？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这些研究中是否有针对抗血管生成药物的比较研究？\n\n<reference text>: 1620</td><td>2016</td><td>12</td><td> NAB-paclitaxel</td><td>nr</td><td>8.9</td></tr><tr><td>Garcia et al.1569</td><td>2007</td><td>27</td><td>Docetaxel</td><td>8.7</td><td>7</td></tr><tr><td>Angiogenesis inhibitors</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Monk et al.\n\n<reply>: ",
  "response": "是的，有研究对抗血管生成药物进行了比较研究。其中一些药物如NAB-紫杉醇和多西紫杉醇等已经被研究比较其效果和副作用。这些抗血管生成药物被广泛用于癌症治疗中，研究比较它们的用途和效果对于指导临床实践具有重要意义。通过对不同抗血管生成药物进行比较研究，可以更好地了解它们在治疗中的表现和适用范围。"
}